3 Rising Stars in the Medical Device Industry

TL;DR

Israeli Imaging device firm Given Imaging, cardiac device maker Biomet, and robotic surgery company Mako Surgical are emerging as top players in the medical device industry.

Transcript

hi fools Dan Carroll here now for many investors there's hardly a better feeling on the markets than finding an under the radar stock just before it blossoms now the medical device industry is home to several top stocks but which up incomers should you be watching for let's check out three of tomorrow's rising stars now Israeli Imaging device firm ... Read More

Key Insights

• 🉐 Given Imaging's PillCam is gaining traction in the market, with potential for significant growth in the US.
• ✋ Biomet's cardiac devices are in high demand in the US market, supported by coverage from major insurers.
• ⏮️ Mako Surgical, despite previous struggles, is starting to show improvement in sales and revenue growth in the robotic surgery industry.
• 😷 Regulatory approval plays a crucial role in the success of medical device companies.
• 😮 Rising costs can impact a company's earnings, but strong demand can offset this.
• 😷 Major insurers' coverage of medical devices can significantly contribute to a company's success.
• 🤘 The success of the robotic surgery industry has been variable, with Mako Surgical demonstrating signs of recovery.

Questions & Answers

Q: What has contributed to Given Imaging's recent sales and revenue growth?

Given Imaging's success can be attributed to the strong sales of its flagship product, the PillCam, and its expanding regulatory approvals in various regions, such as Europe and Japan.

Q: What factors have impacted Biomet's earnings recently?

Although rising costs have affected Biomet's earnings, the demand for its cardiac devices, particularly the impella heart pump, has been surging. The company has thrived in the US market, with several major insurers covering its products under coverage packages.

Q: Why has Mako Surgical struggled in the past?

The robotic surgery industry, including Mako Surgical's main competitor, Intuitive Surgical, has faced challenges such as negative publicity and declining sales. However, Mako Surgical is showing signs of improvement, with increased sales and revenue growth, indicating a turnaround for the company.

Q: What are the growth prospects for these rising stars in the medical device industry?

Given Imaging has the potential for growth in the US market if its PillCam receives regulatory approval. Biomet has strong long-term prospects, with expanding international markets and major insurers covering its products. Mako Surgical is on track to sell a significant number of its Rio systems and has posted revenue growth, indicating a positive future outlook.

Summary & Key Takeaways

• Given Imaging's flagship product, the PillCam, has been gaining strong sales and revenue, with potential for further growth in the United States market.

• Biomet has experienced double-digit revenue growth and increasing demand for its cardiac devices in the US market.

• Mako Surgical has struggled in the past but is showing signs of improvement with increased sales and revenue growth in the robotic surgery industry.